Xvivo Perfusion AB (publ) (STO:XVIVO)

Market Cap	6.10B -53.5%
Revenue (ttm)	812.17M -1.2%
Net Income	25.16M -85.4%
EPS	0.80 -85.3%
Shares Out	31.50M
PE Ratio	242.48
Forward PE	57.65
Dividend	n/a
Ex-Dividend Date	n/a

Volume	166,324
Average Volume	236,974
Open	195.00
Previous Close	193.70
Day's Range	188.80 - 197.80
52-Week Range	160.00 - 481.00
Beta	1.89
RSI	41.61
Earnings Date	Jan 27, 2026

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 198
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: XVIVO

Financial Performance

In 2025, Xvivo Perfusion AB's revenue was 812.17 million, a decrease of -1.25% compared to the previous year's 822.42 million. Earnings were 25.16 million, a decrease of -85.39%.